Most Closely HLA-Matched CTLs for Relapsed Epstein Barr Virus(EBV)-Associated Diseases

计划入组 37 人 · 首次发布于 2011 年 10 月 5 日

Viral Specific T Cell Therapy for COVID-19 Related Pneumonia

计划入组 32 人 · 首次发布于 2021 年 2 月 8 日

Vaccine Therapy With High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma

首次发布于 2003 年 1 月 27 日

MC2 TCR T cells therapy (Erasmus Medical Center)

Allogeneic B7.1/HLA-A1

QEL-001

MEREO BIOPHARMA 2 LIMITED

United Kingdom

UpJohn US 2 LLC

United States

RIVER 2 RENAL CORP.

United States

Novel T-Cell Therapy Trial Aims to Reduce Post-Transplant Relapse in Blood Cancer Patients

FDA Grants Breakthrough Therapy Designation to Adaptimmune's T-Cell Therapy for Synovial Sarcoma

FDA Grants Breakthrough Therapy Designation for Affinity Enhanced T-Cell Therapy in Synovial Sarcoma